Cairo - Mubasher: Kahira Pharmaceuticals’ reported an 18.4% profits increase for the fiscal year 2015-2016, to EGP 51.3 million compared to EGP 43.4 million last year.
The company also recommended distributing cash dividends at EGP 1.35 per share on 24 September, according to a bourse filing.
During its ordinary and extraordinary general meetings the company will discuss the transfer of ownership of a land plot in 6th of October City to Holdipharma.
The land sale is a result of changing the plan to use the plot for constructing a new factory, due to high costs and lack of liquidity.
